1. Home
  2. ULH vs PEPG Comparison

ULH vs PEPG Comparison

Compare ULH & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Universal Logistics Holdings Inc.

ULH

Universal Logistics Holdings Inc.

N/A

Current Price

$14.54

Market Cap

462.1M

Sector

Industrials

ML Signal

N/A

Logo PepGen Inc.

PEPG

PepGen Inc.

N/A

Current Price

$6.29

Market Cap

440.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ULH
PEPG
Founded
1932
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Trucking Freight/Courier Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
462.1M
440.0M
IPO Year
2004
2022

Fundamental Metrics

Financial Performance
Metric
ULH
PEPG
Price
$14.54
$6.29
Analyst Decision
Hold
Strong Buy
Analyst Count
1
6
Target Price
$17.00
$11.67
AVG Volume (30 Days)
33.4K
649.6K
Earning Date
01-01-0001
06-08-2026
Dividend Yield
2.79%
N/A
EPS Growth
39.66
25.61
EPS
N/A
N/A
Revenue
$1,461,708,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.13
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.78
$0.89
52 Week High
$30.76
$7.80

Technical Indicators

Market Signals
Indicator
ULH
PEPG
Relative Strength Index (RSI) 38.90 53.31
Support Level $12.78 $4.36
Resistance Level $18.79 $6.81
Average True Range (ATR) 1.32 0.56
MACD -0.21 -0.05
Stochastic Oscillator 5.36 62.51

Price Performance

Historical Comparison
ULH
PEPG

About ULH Universal Logistics Holdings Inc.

Universal Logistics Holdings Inc is an asset-light provider of customized transportation and logistics solutions throughout the United States, and in Mexico, Canada and Colombia. It offers services such as truckload, brokerage, intermodal, dedicated, and value-added services. The company reports into four segments namely trucking, intermodal, company-managed brokerage, and contract logistics. The majority of the revenue is earned from the contract logistics segment.

About PEPG PepGen Inc.

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.

Share on Social Networks: